Clinical Significance of Serum COL6A3 in Pancreatic Ductal Adenocarcinoma

Journal of Gastrointestinal Surgery

Volumn 18, Issue 1, 2014, Pages 7-15

  Kang, Christopher Y ^a   Wang, Jonathan ^a   Axell House, Dierdre ^a   Soni, Pranay ^a   Chu, Mon Li ^b   Chipitsyna, Galina ^a   Sarosiek, Konrad ^a   Sendecki, Jocelyn ^a   Hyslop, Terry ^a   Al Zoubi, Mazhar ^a   Yeo, Charles J ^a   Arafat, Hwyda A ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

Collagen VI; Diagnostic biomarker; Pancreatic cancer; Serum marker

Indexed keywords

CA 19-9 ANTIGEN; COLLAGEN TYPE 6; MESSENGER RNA; TUMOR MARKER;

ADENOCARCINOMA; AGED; AREA UNDER THE CURVE; ARTICLE; BLOOD; CASE CONTROL STUDY; EXON; FEMALE; GENETICS; HUMAN; INNERVATION; INTESTINE INNERVATION; KAPLAN MEIER METHOD; MALE; MIDDLE AGED; PANCREAS; PANCREAS TUMOR; PATHOLOGY; PROPORTIONAL HAZARDS MODEL; RECEIVER OPERATING CHARACTERISTIC; TUMOR INVASION;

ADENOCARCINOMA; AGED; AREA UNDER CURVE; CA-19-9 ANTIGEN; CASE-CONTROL STUDIES; COLLAGEN TYPE VI; ENTERIC NERVOUS SYSTEM; EXONS; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; PANCREAS; PANCREATIC NEOPLASMS; PROPORTIONAL HAZARDS MODELS; RNA, MESSENGER; ROC CURVE; TUMOR MARKERS, BIOLOGICAL;

EID: 84891859567     PISSN: 1091255X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11605-013-2326-y     Document Type: Article

References (37)

1. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012. CA Cancer J Clin 2012: 62: 10-29.
2. Hidalgo M. Pancreatic cancer. N Engl J Med 2010: 362: 1605-1617.
3. Maitra A, Hruban RH. Pancreatic cancer. Annu Rev Pathol 2008: 3: 157-188.
4. Winter JM, Yeo CJ, Brody JR. Diagnostic, prognostic, and predictive biomarkers in pancreatic cancer. J Surg Oncol 2013: 107: 15-22.
5. Mahadevan D, Von Hoff DD. Tumor-stroma interactions in pancreatic ductal adenocarcinoma. Mol Cancer Ther 2007: 6: 1186-1197.
6. Chu ML, Zhang RZ, Pan TC et al. Mosaic structure of globular domains in the human type VI collagen alpha 3 chain: similarity to von Willebrand factor, fibronectin, actin, salivary proteins and aprotinin type protease inhibitors. EMBO J 1990: 9(2): 385-393.
7. Arafat H, Lazar M, Salem K et al. Tumor-specific expression and alternative splicing of the COL6A3 gene in pancreatic cancer. Surgery 2011: 150: 306-315.
8. Chang KC, Lu YC, Lin MJ, Chen HY, Jin YT. Desmoplastic tumour-associated stroma versus neural tissue in central nervous system metastasis: effects of different microenvironments on tumour growth. Histopathology 2011: 59: 31-39.
9. Lohi J, Leivo I, Oivula J, Lehto V, Virtanen I. Extracellular matrix in renal cell carcinomas. Histol Histopathol 1998: 13: 785-796.
10. Sethi T, Rintoul RC, Moore SM et al. Extracellular matrix proteins protect small cell lung cancer cells against apoptosis: a mechanism for small cell lung cancer growth and drug resistance in vivo. Nat Med 1999: 5: 662-668.
11. Sherman-Baust CA, Weeraratna AT, Rangel L et al. Remodeling of the extracellular matrix through overexpression of collagen VI contributes to cisplatin resistance in ovarian cancer cells. Cancer cell 2003: 3: 377-386.
12. Ohlund D, Lundin C, Ardnor B, Oman M, Naredi P, Sund M. Type IV collagen is a tumour stroma-derived biomarker for pancreas cancer. Br J Cancer 2009: 101: 91-97.
13. Mazouni C, Arun B, Andre F et al. Collagen IV levels are elevated in the serum of patients with primary breast cancer compared to healthy volunteers. Br J Cancer 2008: 99: 68-71.
14. Ohlund D, Franklin O, Lundberg E, Lundin C, Sund M. Type IV collagen stimulates pancreatic cancer cell proliferation, migration, and inhibits apoptosis through an autocrine loop. BMC Cancer (2013). DOI: 13: 154-2407-13-154.
15. Shields MA, Dangi-Garimella S, Krantz SB, Bentrem DJ, Munshi HG. Pancreatic cancer cells respond to type I collagen by inducing snail expression to promote membrane type 1 matrix metalloproteinase-dependent collagen invasion. J Biol Chem 2011: 286: 10495-10504. (duplicate of ref. 11).
16. Sherman-Baust CA, Weeraratna AT, Rangel L et al. Remodeling of the extracellular matrix through overexpression of collagen VI contributes to cisplatin resistance in ovarian cancer cells. Cancer cell 2003: 3: 377-386.
17. Miyamoto H, Murakami T, Tsuchida K, Sugino H, Miyake H, Tashiro S. Tumor-stroma interaction of human pancreatic cancer: acquired resistance to anticancer drugs and proliferation regulation is dependent on extracellular matrix proteins. Pancreas 2004: 28: 38-44.
18. Korc M. Pancreatic cancer-associated stroma production. Am J Surg 2007: 194: S84-S86.
19. Lynch SM, Vrieling A, Lubin JH et al. Cigarette smoking and pancreatic cancer: a pooled analysis from the pancreatic cancer cohort consortium. Am J Epidemiol 2009: 170: 403-413.
20. Lowenfels AB, Maisonneuve P. Epidemiology and risk factors for pancreatic cancer. Best Practice and Research: Clinical Gastroenterology 2006: 20: 197-209.
21. Heeschen C, Jang JJ, Weis M et al. Nicotine stimulates angiogenesis and promotes tumor growth and atherosclerosis. Nat Med 2001: 7: 833-839.
22. Bose C, Zhang H, Udupa KB, Chowdhury P. Activation of p-ERK1/2 by nicotine in pancreatic tumor cell line AR42J: effects on proliferation and secretion. Am J Physiol Gastrointest Liver Physiol 2005: 289: G926-34.
23. Chowdhury P, Bose C, Udupa KB. Nicotine-induced proliferation of isolated rat pancreatic acinar cells: effect on cell signalling and function. Cell Prolif 2007: 40: 125-141.
24. Lazar M, Sullivan J, Chipitsyna G et al. Involvement of osteopontin in the matrix-degrading and proangiogenic changes mediated by nicotine in pancreatic cancer cells. J Gastrointest Surg 2010: 14: 1566-1577.
25. Mahadevan D, Von Hoff DD. Tumor-stroma interactions in pancreatic ductal adenocarcinoma. Mol Cancer Ther 2007: 6: 1186-1197.
26. Makareeva E, Han S, Vera JC et al. Carcinomas contain a matrix metalloproteinase-resistant isoform of type I collagen exerting selective support to invasion. Cancer Res 2010: 70: 4366-4374.
27. Stallings-Mann M, Radisky D. Matrix metalloproteinase-induced malignancy in mammary epithelial cells. Cells Tissues Organs 2007: 185: 104-110.
28. Zhou J, Olson BL, Windsor LJ. Nicotine increases the collagen-degrading ability of human gingival fibroblasts. J Periodontal Res 2007: 42: 228-235.
29. Heeschen C, Jang JJ, Weis M et al. Nicotine stimulates angiogenesis and promotes tumor growth and atherosclerosis. Nat Med 2001: 7: 833-839.
30. Tipton DA, Dabbous MK. Effects of nicotine on proliferation and extracellular matrix production of human gingival fibroblasts in vitro. J Periodontol 1995: 66: 1056-1064.
31. Singh S, Tang SJ, Sreenarasimhaiah J, Lara LF, Siddiqui A. The clinical utility and limitations of serum carbohydrate antigen (CA19-9) as a diagnostic tool for pancreatic cancer and cholangiocarcinoma. Dig Dis Sci 2011: 56: 2491-2496.
32. Winter JM, Yeo CJ, Brody JR. Diagnostic, prognostic, and predictive biomarkers in pancreatic cancer. J Surg Oncol 2013: 107: 15-22.
33. Yang S, Shin J, Park KH et al. Molecular basis of the differences between normal and tumor tissues of gastric cancer. Biochimica et biophysica acta. Molecular basis of disease 2007: 1772: 1033-1040.
34. Thorsen K, Sorensen KD, Brems-Eskildsen AS et al. Alternative splicing in colon, bladder, and prostate cancer identified by exon array analysis. Mol Cell Proteomics 2008: 7: 1214-1224.
35. Farkas DH, Kaul KL, Wiedbrauk DL, Kiechle FL. Specimen collection and storage for diagnostic molecular pathology investigation. Arch Pathol Lab Med 1996: 120: 591-596.
36. Kopreski MS, Benko FA, Kwak LW, Gocke CD. Detection of tumor messenger RNA in the serum of patients with malignant melanoma. Clin Cancer Res 1999: 5: 1961-1965.
37. Hunt JL. Molecular pathology in anatomic pathology practice: a review of basic principles. Arch Pathol Lab Med 2008: 132: 248-260.